| Nusinersen versus sham control in infantile-onset spinal muscular atrophy RS Finkel, E Mercuri, BT Darras, AM Connolly, NL Kuntz, J Kirschner, ... New England Journal of Medicine 377 (18), 1723-1732, 2017 | 1966 | 2017 |
| Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care E Mercuri, RS Finkel, F Muntoni, B Wirth, J Montes, M Main, ES Mazzone, ... Neuromuscular disorders 28 (2), 103-115, 2018 | 874 | 2018 |
| Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1 A Yoshida, K Kobayashi, H Manya, K Taniguchi, H Kano, M Mizuno, ... Developmental cell 1 (5), 717-724, 2001 | 852 | 2001 |
| Mutations in the laminin α2–chain gene (LAMA2) cause merosin–deficient congenital muscular dystrophy A Helbling-Leclerc, X Zhang, H Topaloglu, C Cruaud, F Tesson, ... Nature genetics 11 (2), 216-218, 1995 | 747 | 1995 |
| Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study D De Vivo, E Bertini, K Swoboda, WL Hwu, T Crawford, R Finkel, ... Neuromuscular Disorders 29 (11), 2019 | 508 | 2019 |
| Refining genotype–phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan C Godfrey, E Clement, R Mein, M Brockington, J Smith, B Talim, V Straub, ... Brain 130 (10), 2725-2735, 2007 | 454 | 2007 |
| Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial CM McDonald, C Campbell, RE Torricelli, RS Finkel, KM Flanigan, ... The Lancet 390 (10101), 1489-1498, 2017 | 445 | 2017 |
| The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy P Bomont, L Cavalier, F Blondeau, CB Hamida, S Belal, M Tazir, E Demir, ... Nature genetics 26 (3), 370-374, 2000 | 427 | 2000 |
| European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task … PYK Van den Bergh, PA van Doorn, RDM Hadden, B Avau, ... Journal of the Peripheral Nervous System 26 (3), 242-268, 2021 | 418 | 2021 |
| Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome B Moghadaszadeh, N Petit, C Jaillard, M Brockington, SQ Roy, L Merlini, ... Nature genetics 29 (1), 17-18, 2001 | 391 | 2001 |
| Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study T Voit, H Topaloglu, V Straub, F Muntoni, N Deconinck, G Campion, ... The Lancet Neurology 13 (10), 987-996, 2014 | 373 | 2014 |
| Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies RW Taylor, A Pyle, H Griffin, EL Blakely, J Duff, L He, T Smertenko, ... Jama 312 (1), 68-77, 2014 | 368 | 2014 |
| The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene K Gempel, H Topaloglu, B Talim, P Schneiderat, BGH Schoser, VH Hans, ... Brain 130 (8), 2037-2044, 2007 | 364 | 2007 |
| Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia) S Nicole, CS Davoine, H Topaloglu, L Cattolico, D Barral, P Beighton, ... Nature genetics 26 (4), 480-483, 2000 | 341 | 2000 |
| Deciphering the glycosylome of dystroglycanopathies using haploid screens for lassa virus entry LT Jae, M Raaben, M Riemersma, E Van Beusekom, VA Blomen, A Velds, ... Science 340 (6131), 479-483, 2013 | 301 | 2013 |
| Mutations in SIL1 cause Marinesco-Sjögren syndrome, a cerebellar ataxia with cataract and myopathy J Senderek, M Krieger, C Stendel, C Bergmann, M Moser, ... Nature genetics 37 (12), 1312-1314, 2005 | 289 | 2005 |
| A dystroglycan mutation associated with limb-girdle muscular dystrophy Y Hara, B Balci-Hayta, T Yoshida-Moriguchi, M Kanagawa, ... New England Journal of Medicine 364 (10), 939-946, 2011 | 285 | 2011 |
| Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy I Kurth, T Pamminger, JC Hennings, D Soehendra, AK Huebner, ... Nature genetics 41 (11), 1179-1181, 2009 | 242 | 2009 |
| Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy J Senderek, C Bergmann, C Stendel, J Kirfel, N Verpoorten, P De Jonghe, ... The American Journal of Human Genetics 73 (5), 1106-1119, 2003 | 242 | 2003 |
| Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping D Hillaire, A Leclerc, S Fauré, H Topaloglu, N Chiannllkulchai, ... Human molecular genetics 3 (9), 1657-1661, 1994 | 238 | 1994 |
